Listen "Reasons for Setting Up Natural History Studies & Their Challenges"
Episode Synopsis
Listen as Rachel Smith, Portfolio Director at Veristat, reviews considerations for setting up Natural History studies and the value they bring to rare and ultra-rare clinical research, despite the challenges in their design.
More episodes of the podcast Advancing Revolutionary Therapies
CMC Pitfalls: From Benchtop to IND
31/10/2022
Emergency Use Authorizations
22/09/2022
Orphan Drug Designations and Orphan Subsets
11/09/2022
Season 3 Trailer
26/08/2022
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.